Therapy With Direct-Acting Antivirals for Genotype 3 Patients: Interferon’s Last Gasp? Rafael Esteban, Maria Buti Gastroenterology Volume 149, Issue 6, Pages 1326-1330 (November 2015) DOI: 10.1053/j.gastro.2015.09.032 Copyright © 2015 AGA Institute Terms and Conditions
Figure 1 Sustained virologic response rates with different therapeutic regimens (A) in patients without cirrhosis (B) in patients with cirrhosis. Gastroenterology 2015 149, 1326-1330DOI: (10.1053/j.gastro.2015.09.032) Copyright © 2015 AGA Institute Terms and Conditions